- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Why Are Benefits of Preventive Drug Lists Not Fully Realized for Patients With Asthma?
On this episode of Managed Care Cast, we speak with 2 authors of a recent study who researched how useful preventive drug lists are for patients with asthma and parents of children with asthma.
When implemented as intended, preventive drug lists (PDLs) can help high-deductible health plan members save money by covering preventive medications at lower or no costs. However, after conducting a series of interviews, researchers found this is not always the case among patients with asthma who have PDLs. Some patients were unaware they even had access to PDLs, while others found PDLs did not cover the cost of asthma medication.
On this episode of Managed Care Cast, we speak with Melissa B. Gilkey, PhD, and Alison A. Galbraith, MD, MPH, about their paper, "Preventive Drug Lists as Tools for Managing Asthma Medication Costs." The study can be found in the February issue of The American Journal of Managed Care®.
Listen above or through one of these podcast services:
Depemokimab Reduces Exacerbations Regardless of Baseline Asthma Control
July 3rd 2025Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being reviewed by the FDA.
Read More
